News

Biogen Idec has received similar approval from the European Medicines Agency for the high titer process in December 2008. The new, higher-yield process will be used to manufacture

The newborn and preterm infant population has varying degrees of fragile, underdeveloped skin that can be easily damaged by adhesives. Coupled with Casmed’s unique Cool-Light technology which eliminates

The company has reported a revenue of $1.04 billion for the first quarter of 2009, a 10% increase, compared to $942.19 million for the first quarter of 2008.

The company has reported net sales of $2.82 billion for the first quarter of 2009, a decrease of 2%, compared to $2.87 billion for the first quarter of

Funding for research using adult stem cells and induced pluripotent stem cells will continue. Funding will not be allowed for stem cells obtained from other sources, including somatic

Kowa Pharmaceuticals America, a specialty pharmaceutical company, has plans to divest its franchise of diclofenac products, including PRO-513 for the treatment of acute migraine headache pain and PRO-571

PPG Industries, a manufacturer of chemical products, reports a net loss of $111m in the first quarter, compared to a net loss of $100m for the same period

Industry, nonprofit and government experts shared their insights on a variety of topics, including the future of chemicals management and TSCA reform, coping with the latest Global Harmonization

Genomic Health, a life science company, has reported that the Quasar validation study met its primary endpoint to predict the likelihood of recurrence for stage II colon cancer